A recent study indicated that the famous medical device company HeartWare production of heart implanted pump system can effectively extend the life of patients with heart failure, this research will undoubtedly make HeartWare company and another company production weight exceeds twice the amount of similar instruments of the company's competitive advantage.
HeartWare production of 5 ounces implanted pump in the United States has not yet been approved for production.
This new instrument will be implanted in patients with left ventricular, helps loss heart pushes the blood with oxygen to other organs of the body. Researchers at Chicago, United States Heart Association meeting that patients receive the instrument implantation after 6 months, the survival rate reached 92%, and further heart transplant or treatment well and removal of implants pump.In the United States upon approval, is HeartWare corporate will be worth $ 4 billion medical devices market and is located in California's Thoratec Corporation competition.
Thoratec Corporation production of 10 oz heart implanted pump in 2009 set 2.3 billion in sales. Louisville University researcher mark-downs Laut (Mark Slaughter) analysis that the weight of the smaller pressure pump to implantation process reduce surgical trauma and the needs of the dynamic energy is also smaller.
No comments:
Post a Comment